by Francisca Peixoto | Mar 3, 2022 | Uncategorized
We are pleased to announce that our portfolio company Accure Therapeutics signed an exclusive worldwide licensing agreement with Oculis to develop and commercialise a potentially disease modifying therapy to protect and prevent damage to the optic nerve and retina....
by Francisca Peixoto | Dec 22, 2021 | Uncategorized
As the year comes to a close, LifeLink Ventures releases its Annual Biotech Report. We wish to connect private investors with emerging technologies that address global health challenges. To do so, first we must bring our investors closer to the biotech world. Learn...
by Francisca Peixoto | Jun 16, 2021 | Uncategorized
Our portfolio company CEBINA was founded with the aim of creating, nurturing, and promoting early-stage life sciences companies in central Europe. CEBINA incubates and accelerates promising projects in the biotech field. Now, CEBINA has joined forces with the...
by Francisca Peixoto | Mar 18, 2021 | Uncategorized
For our latest newsletter we have compiled a summary of the efficacy and side effects for the first generation of Covid-19 vaccines. We aim to provide a reliable source of biotechnological information for the public. To access the full document please click here:...
